Calyxt Stock

Calyxt Liabilities

Delisted

The The Liabilities of Calyxt (CLXT) as of Aug 13, 2026 is 15.19 M USD. In the previous year, The Liabilities was 23.06 M USD — a change of -34.14% (lower).

Liabilities

15.19 MUSD

YoY

-34.14%

Last updated:

In 2026, Calyxt's total liabilities amounted to 15.19 M USD, a -34.14% difference from the 23.06 M USD total liabilities in the previous year.

Access this data via the Eulerpool API

Calyxt Stock analysis

What does Calyxt do? Calyxt Inc. is a US company specializing in the development and marketing of genetically modified plants. The company was founded in Minnesota in 2010 with the aim of producing high-quality, healthy, and environmentally friendly products that meet the requirements of modern and sustainable nutrition. History The history of Calyxt Inc. began with the idea of revolutionizing the cultivation of crops. The company was founded by Cellectis SA, which already had experience in the field of molecular biology. Calyxt developed technological processes for rapid genetic manipulation of plants that had the potential to change the entire agricultural industry. Business Model Calyxt follows an "end-to-end" business model, meaning the company offers products and services along the entire value chain. This ranges from the development of new plants through genetic modifications to the distribution and marketing of the end products. Divisions Calyxt specializes in the development of plant varieties optimized through genetic manipulation. The company has various divisions that focus on specific plant species, including: - Soybeans: Calyxt has developed a new variety of soybeans that contains a higher proportion of oleic acid, which improves the durability and quality of the beans. - Wheat: The company has also developed a variety of wheat that is low in gluten. This allows people with celiac disease or other reasons to avoid gluten to consume this variety. - Potatoes: Calyxt has developed a new variety of potatoes that contains less acrylamide than other varieties. Acrylamide is formed during the production of fries and chips and is suspected to cause cancer. Products Calyxt offers various products made from the plants they have developed, including: - Soybean oil: Calyxt soybean oil contains a higher proportion of healthy omega-3 fatty acids compared to conventional soybean oil. - Flour: Calyxt wheat flour is low in gluten and can be consumed by people with celiac disease or other reasons to avoid gluten. - Fries and chips: Calyxt potatoes contain less acrylamide than conventional potatoes, resulting in the formation of fewer harmful substances during the preparation of fries and chips. Conclusion Calyxt Inc. is an American company that develops genetically modified plants and connects them with customers, mainly in the food sector. The company aims to produce healthy, environmentally friendly, and high-quality products that meet the requirements of modern and sustainable nutrition. Various plant species are genetically modified to improve the durability and quality of the products while minimizing health risks. Calyxt Inc. offers various products made from the plants they have developed, with a focus on the production of fries and chips, as well as the distribution of soybean oil and low-gluten wheat flour. Calyxt has the potential to change modern agriculture through its innovative and sustainable products. Calyxt is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Calyxt's Liabilities

Calyxt's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Calyxt's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Calyxt's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Calyxt's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Calyxt’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Calyxt stock

The Liabilities of Calyxt is 15.19 M USD in 2026.

The Liabilities of Calyxt changed from 23.06 M USD to 15.19 M USD, representing a -34.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Calyxt since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Calyxt historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Calyxt

All Key Metrics — Calyxt